An Investigational Study Examining the Cross-Validation of QbMobile in ADHD and Normative Populations
Enrolling by invitation
Conditions studied: No History of ADHD, Attention Deficit Hyperactivity Disorder (ADHD), Healthy Volunteer
In brief
The purpose of this study is to investigate QbMobile ability to collect and provide accurate and objective data which can be used to facilitate assessment and treatment procedures for ADHD in a clinical setting as well as remotely.
Key facts
- Study ID
- NCT07220330
- Run by
- Qbtech AB
- People needed
- 700
- Starts
- 2025-01-15
- Expected to finish
- 2026-10-01
- Last updated by the study team
- 2026-05-06
Who can join
Age: 6 and older, up to 60. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Provide written informed consent (including parent/legal guardians consent when this is required for individuals under 18 years old and assent as is required based on the age of participant) for QbMobile;
- Aged > 6 years and < 60 years old;
- Have no documented or suspected current or lifetime diagnosis of ADHD or referred for an initial assessment for ADHD or have a diagnosis of ADHD but not currently receiving treatment;
- Meet DSM-5 or ICD-11 criteria for a primary diagnosis of ADHD (combined, inattentive, or hyperactivity/impulsive presentation) per sites standard clinical care evaluation;
- Qbtech Rating Scale total score of >24 at Visit 1;
- Have adequate sensory and physical ability to complete QbMobile;
- Possess or has access to an iPhone model that supports QbMobile.
You may not qualify if…
- Intellectual disability designated by IQ<75;
- Has used psychostimulant medication within the past 7 days prior to Visit 1;
- A current medical diagnosis that could significantly affect test performance (brain injuries, Parkinson's disease, current epilepsy or active seizures, amyotrophic lateral sclerosis (ALS), multiple sclerosis, dementias (e.g., vascular dementia, Alzheimer disease, etc.);
- Other conditions that could affect test performance (migraine or other types of severe headache, chronic or acute pain);
- Substance use (e.g., alcohol, drugs) that may affect performance on the day of the tests.
Where it is running
- Prodigy Psychiatric Group — San Jose, California, United States
- Bokhari Medical Consortium — Largo, Florida, United States
- Nona Pediatric Center — Orlando, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.